Validated Alzheimer's Disease Risk Index (ANU-ADRI) is associated with smaller volumes in the default mode network in the early 60s
| dc.contributor.author | Cherbuin, Nicolas | |
| dc.contributor.author | Shaw, Marnie | |
| dc.contributor.author | Walsh, Erin | |
| dc.contributor.author | Sachdev, Perminder Singh | |
| dc.contributor.author | Anstey, Kaarin | |
| dc.date.accessioned | 2022-02-04T01:15:29Z | |
| dc.date.available | 2022-02-04T01:15:29Z | |
| dc.date.issued | 2019 | |
| dc.date.updated | 2020-12-13T07:20:04Z | |
| dc.description.abstract | Strong evidence is available suggesting that effective reduction of exposure to demonstrated modifiable risk factors in mid-life or before could significantly decrease the incidence of Alzheimer's disease (AD) and delay its onset. A key ingredient to achieving this goal is the reliable identification of individuals at risk well before they develop clinical symptoms. The aim of this study was to provide further neuroimaging evidence of the effectiveness of a validated tool, the ANU Alzheimer's Disease Risk Index, for the assessment of future risk of cognitive decline. Participants were 461 (60-64 years, 48% female) community-living individuals free of dementia at baseline. Associations between risk estimates obtained with the ANU-ADRI, total and regional brain volumes including in the default mode network (DMN) measured at the same assessment and diagnosis of MCI/dementia over a 12-year follow-up were tested in a large sample of community-living individuals free of dementia at baseline. Higher risk estimates on the ANU-ADRI were associated with lower cortical gray matter and particularly in the DMN. Importantly, difference in participants with high and low risk scores explained 7% of the observed difference in gray matter volume. In this sample, every one additional risk point on the ANU-ADRI was associated with an 8% increased risk of developing MCI/dementia over a 12-year follow-up and this association was partly mediated by a sub-region of the DMN. Risk of cognitive decline assessed with a validated instrument is associated with gray matter volume, particularly in the DMN, a region known to be implicated in the pathological process of the disease. | en_AU |
| dc.format.mimetype | application/pdf | en_AU |
| dc.identifier.issn | 1931-7557 | en_AU |
| dc.identifier.uri | http://hdl.handle.net/1885/259065 | |
| dc.language.iso | en_AU | en_AU |
| dc.provenance | This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. | en_AU |
| dc.publisher | Springer | en_AU |
| dc.relation | http://purl.org/au-research/grants/nhmrc/973302 | en_AU |
| dc.relation | http://purl.org/au-research/grants/nhmrc/179805 | en_AU |
| dc.relation | http://purl.org/au-research/grants/nhmrc/157125 | en_AU |
| dc.relation | http://purl.org/au-research/grants/nhmrc/1063907 | en_AU |
| dc.relation | http://purl.org/au-research/grants/arc/FT120100227 | en_AU |
| dc.relation | http://purl.org/au-research/grants/nhmrc/1002560 | en_AU |
| dc.rights | © The Author(s) 2017. This article is an open access publication | en_AU |
| dc.rights.license | Creative Commons Attribution 4.0 International License | en_AU |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_AU |
| dc.source | Brain Imaging and Behavior | en_AU |
| dc.subject | Dementia risk | en_AU |
| dc.subject | ANU-ADRI | en_AU |
| dc.subject | DMN | en_AU |
| dc.subject | MRI | en_AU |
| dc.subject | MCI | en_AU |
| dc.title | Validated Alzheimer's Disease Risk Index (ANU-ADRI) is associated with smaller volumes in the default mode network in the early 60s | en_AU |
| dc.type | Journal article | en_AU |
| dcterms.accessRights | Open Access | en_AU |
| local.bibliographicCitation.issue | 1 | en_AU |
| local.bibliographicCitation.lastpage | 74 | en_AU |
| local.bibliographicCitation.startpage | 65 | en_AU |
| local.contributor.affiliation | Cherbuin, Nicolas, College of Health and Medicine, ANU | en_AU |
| local.contributor.affiliation | Shaw, Marnie, College of Engineering and Computer Science, ANU | en_AU |
| local.contributor.affiliation | Walsh, Erin, College of Health and Medicine, ANU | en_AU |
| local.contributor.affiliation | Sachdev, Perminder Singh, University of New South Wales | en_AU |
| local.contributor.affiliation | Anstey, Kaarin, College of Health and Medicine, ANU | en_AU |
| local.contributor.authoruid | Cherbuin, Nicolas, u3184049 | en_AU |
| local.contributor.authoruid | Shaw, Marnie, u3627775 | en_AU |
| local.contributor.authoruid | Walsh, Erin, u4402564 | en_AU |
| local.contributor.authoruid | Anstey, Kaarin, u4038535 | en_AU |
| local.description.notes | Imported from ARIES | en_AU |
| local.identifier.absfor | 111702 - Aged Health Care | en_AU |
| local.identifier.absseo | 920502 - Health Related to Ageing | en_AU |
| local.identifier.ariespublication | a383154xPUB9856 | en_AU |
| local.identifier.citationvolume | 13 | en_AU |
| local.identifier.doi | 10.1007/s11682-017-9789-5 | en_AU |
| local.identifier.scopusID | 2-s2.0-85038113206 | |
| local.publisher.url | https://link.springer.com/ | en_AU |
| local.type.status | Published Version | en_AU |
Downloads
Original bundle
1 - 1 of 1
Loading...
- Name:
- 01_Cherbuin_Validated_Alzheimer%27s_Disease_2017.pdf
- Size:
- 1.11 MB
- Format:
- Adobe Portable Document Format